<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-10T15:53:26Z</responseDate>
  <request identifier="oai:figshare.com:article/33958385" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33958385</identifier>
        <datestamp>2026-09-21T17:53:44Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>category_134</setSpec>
        <setSpec>category_135</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Baseline characteristics of the study population after exclusion.&lt;/p&gt;</dc:title>
          <dc:creator>Ernst Bergman (25084952)</dc:creator>
          <dc:creator>Anna Nordström (262623)</dc:creator>
          <dc:creator>Lars Nyberg (28200)</dc:creator>
          <dc:creator>Peter Nordström (262624)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>Virology</dc:subject>
          <dc:subject>Computational  Biology</dc:subject>
          <dc:subject>without structured long</dc:subject>
          <dc:subject>ume &amp;# 229</dc:subject>
          <dc:subject>introduced selection bias</dc:subject>
          <dc:subject>first recorded diagnosis</dc:subject>
          <dc:subject>first dispensed glucose</dc:subject>
          <dc:subject>controlled trial conditions</dc:subject>
          <dc:subject>broadly consistent across</dc:subject>
          <dc:subject>46 percentage points</dc:subject>
          <dc:subject>42 percentage points</dc:subject>
          <dc:subject>individualized motivational counseling</dc:subject>
          <dc:subject>comprehensive health assessment</dc:subject>
          <dc:subject>standard deviation 2</dc:subject>
          <dc:subject>based cohort study</dc:subject>
          <dc:subject>intervention &amp;# 8217</dc:subject>
          <dc:subject>association remained stable</dc:subject>
          <dc:subject>absolute risk reduction</dc:subject>
          <dc:subject>8 %) controls</dc:subject>
          <dc:subject>543 matched controls</dc:subject>
          <dc:subject>evaluated whether participation</dc:subject>
          <dc:subject>general swedish population</dc:subject>
          <dc:subject>6 %) participants</dc:subject>
          <dc:subject>intervention cohort</dc:subject>
          <dc:subject>nationwide health</dc:subject>
          <dc:subject>counseling program</dc:subject>
          <dc:subject>8 years</dc:subject>
          <dc:subject>control cohort</dc:subject>
          <dc:subject>intervention ’</dc:subject>
          <dc:subject>intervention program</dc:subject>
          <dc:subject>intervention consisted</dc:subject>
          <dc:subject>xlink "&gt;</dc:subject>
          <dc:subject>volunteer effect</dc:subject>
          <dc:subject>term follow</dc:subject>
          <dc:subject>specialist care</dc:subject>
          <dc:subject>routine care</dc:subject>
          <dc:subject>robust evidence</dc:subject>
          <dc:subject>risk approaches</dc:subject>
          <dc:subject>reduced incidence</dc:subject>
          <dc:subject>program may</dc:subject>
          <dc:subject>primary outcome</dc:subject>
          <dc:subject>old residents</dc:subject>
          <dc:subject>observed association</dc:subject>
          <dc:subject>mean follow</dc:subject>
          <dc:subject>lowering medication</dc:subject>
          <dc:subject>lower risk</dc:subject>
          <dc:subject>lower incidence</dc:subject>
          <dc:subject>healthcare burden</dc:subject>
          <dc:subject>findings suggest</dc:subject>
          <dc:description>&lt;p&gt;Baseline characteristics of the study population after exclusion.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-21T17:54:03Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pmed.1005043.t001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Baseline_characteristics_of_the_study_population_after_exclusion_p_/33958385</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
